We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Sgx Pharmaceuticals (MM) | NASDAQ:SGXP | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 3.00 | 0 | 00:00:00 |
Delaware | 06-1523147 | |
(State or other jurisdiction of incorporation or | (I.R.S. Employer Identification No.) | |
organization) | ||
10505 Roselle Street | 92121 | |
San Diego, California | (Zip Code) | |
(Address of Principal Executive Offices) |
Annette North, Esq. | Frederick T. Muto, Esq. | |
General Counsel and | J. Patrick Loofbourrow, Esq. | |
Corporate Secretary | Cooley Godward Kronish LLP | |
SGX Pharmaceuticals, Inc. | 4401 Eastgate Mall | |
10505 Roselle Street | San Diego, CA 92121 | |
San Diego, CA 92121 | (858) 550-6000 | |
(858) 558-4850 |
Large accelerated filer o | Accelerated filer o | Non-accelerated filer o | Smaller reporting company þ | |||
(Do not check if a smaller reporting company) |
Proposed | ||||||||||||||
Maximum | Proposed Maximum | |||||||||||||
Title of Each Class of Securities to | Amount to be | Offering | Aggregate | Amount of | ||||||||||
be Registered | Registered (1) | Price per Share (2) | Offering Price (2) | Registration Fee | ||||||||||
Common Stock issuable under the
2005 Equity Incentive Plan (par
value $0.001 per share)
|
500,000 shares(3) | $1.355 | $677,500 | $26.63 | ||||||||||
Common Stock issuable under the
2005 Employee Stock Purchase Plan
(par value $0.001 per share)
|
150,000 shares(4) | $1.355 | $203,250 | $ 7.98 | ||||||||||
Common Stock issuable under the
2005 Non-Employee Directors Stock Option Plan
(par value $0.001) per share
|
62,500 (5) | $1.355 | $ 84,688 | $ 3.33 | ||||||||||
Total
|
712,500 shares | N/A | $965,438 | $37.94 | ||||||||||
(1) |
Pursuant to Rule 416(a) under the Securities Act of 1933, as amended
(the
Securities Act
), this Registration Statement on Form S-8
( Registration Statement ) also registers any additional shares of the Registrants common stock, par value $0.001 per share (the Common Stock ), as may become issuable under the plans as a result of any stock split, stock dividend, recapitalization or other similar transaction. |
|
(2) | Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(c) and Rule 457(h)(1) under the Securities Act. The price per share and aggregate offering price are based upon the average of the high and low prices of the Registrants Common Stock on May 21, 2008, as reported on the Nasdaq Global Market. | |
(3) | Represents shares of Common Stock that were automatically added to the shares authorized for issuance under the Registrants 2005 Equity Incentive Plan (the 2005 EIP ) on January 1, 2008 pursuant to an evergreen provision contained in the 2005 EIP. Pursuant to such provision, on January 1 st of each year commencing in 2007 and ending on (and including) January 1, 2015, the number of shares authorized for issuance under the 2005 EIP is automatically increased by a number equal to the lesser of (i) three and one half percent (3 1/2 %) of the total number of shares of Common Stock outstanding on December 31 st of the preceding calendar year (rounded up to the nearest whole share), (ii) 500,000 shares of Common Stock or (iii) an amount determined by the Registrants Board of Directors or a duly authorized committee of the Board of Directors. | |
(4) | Represents shares of Common Stock that were automatically added to the shares authorized for issuance under the Registrants 2005 Employee Stock Purchase Plan (the 2005 ESPP ) on January 1, 2008 pursuant to an evergreen provision contained in the 2005 ESPP. Pursuant to such provision, on the first day of the Registrants fiscal year beginning in 2007 and ending in (and including) 2015, the number of shares authorized for issuance under the 2005 ESPP is automatically increased by a number equal to the lesser of (i) one percent (1%) of the total number of shares of Common Stock outstanding on December 31 st of the preceding year (rounded to the nearest whole share), (ii) 150,000 shares of Common Stock, or (iii) an amount determined by the Registrants Board of Directors or a duly authorized committee of the Board of Directors. | |
(5) | Represents shares of Common Stock that were automatically added to the shares authorized for issuance under the Registrants 2005 Non-Employee Directors Stock Option Plan (the Directors Plan ) on January 1, 2008 pursuant to an evergreen provision contained in the Directors Plan. Pursuant to such provision, on the first day of the Registrants fiscal year beginning in 2007 and ending in (and including) 2015, the number of shares authorized for issuance under the Directors Plan is automatically increased by a number equal to the lesser of (i) the aggregate number of shares of Common Stock subject to options granted under the Directors Plan as initial grants and annual grants during the immediately preceding fiscal year, or (ii) an amount determined by the Registrants Board of Directors or a duly authorized committee of the Board of Directors. |
INCORPORATION BY REFERENCE OF CONTENTS OF REGISTRATION STATEMENTS ON FORM S-8 NO. 333-131428 | ||||||||
EXHIBITS | ||||||||
SIGNATURES | ||||||||
POWER OF ATTORNEY | ||||||||
EXHIBIT INDEX | ||||||||
EXHIBIT 5.1 | ||||||||
EXHIBIT 23.1 |
Exhibit | ||
Number | Description | |
4.1
(1)
|
Form of Registrants Amended and Restated Certificate of Incorporation. | |
|
||
4.2
(2)
|
Form of Registrants Amended and Restated Bylaws. | |
|
||
4.3
(3)
|
Form of Common Stock Certificate of the Registrant. | |
|
||
5.1
|
Opinion of Cooley Godward Kronish LLP. | |
|
||
23.1
|
Consent of Independent Registered Public Accounting Firm. | |
|
||
23.2
|
Consent of Cooley Godward Kronish LLP. Reference is made to Exhibit 5.1. | |
|
||
24.1
|
Power of Attorney. Reference is made to the signature page of this Form S-8. | |
|
||
99.1
(3)
|
2005 Equity Incentive Plan and Form of Stock Option Agreement and Form of Stock Option Grant Notice thereunder. | |
|
||
99.2
(4)
|
Form of Restricted Stock Unit Grant Notice and Restricted Stock Unit Agreement for Executive Officers under the Registrants 2005 Equity Incentive Plan. | |
|
||
99.3
(3)
|
2005 Employee Stock Purchase Plan and Form of Offering Document thereunder. | |
|
||
99.4
(5)
|
2005 Non-Employee Directors Stock Option Plan and Form of Stock Option Agreement and Form of Stock Option Grant Notice thereunder. |
(1) | Filed as an exhibit to the Registrants Registration Statement on Form S-1 (File No. 33-128059) filed with the Commission on September 2, 2005, and incorporated herein by reference. | |
(2) | Filed as an exhibit to the Registrants Annual Report on Form 10-K (File No. 000-51745 ) for the year ended December 31, 2006 filed with the Commission on March 30, 2007, and incorporated herein by reference. | |
(3) | Filed as an exhibit to Amendment No. 4 to the Registrants Registration Statement on Form S-1 (File No. 33-128059) filed with the Commission on January 4, 2006, and incorporated herein by reference. | |
(4) | Filed as an exhibit to the Registrants Annual Report on Form 10-K (File No. 000-51745) for the year ended December 31, 2005 filed with the Commission on March 31, 2006, and incorporated herein by reference. | |
(5) | Filed as an exhibit to the Registrants Quarterly Report on Form 10-Q (File No. 000-51745) filed with the Commission on August 14, 2007, and incorporated herein by reference. |
SGX PHARMACEUTICALS, INC.
|
||||
By: | /s/ Michael Grey | |||
Michael Grey | ||||
Chief Executive Officer | ||||
Signature | Title | Date | ||
/s/ Michael Grey
|
President, Chief Executive Officer and
Member of the Board of Directors (Principal Executive Officer) |
May 27, 2008 | ||
|
||||
/s/ Todd Myers
|
Chief Financial Officer
(Principal Financial and Accounting Officer) |
May 27, 2008 | ||
|
||||
/s/ Christopher S. Henney
|
Chairman of the Board of Directors | May 27, 2008 | ||
|
||||
/s/ Louis C. Bock
|
Member of the Board of Directors | May 27, 2008 | ||
|
||||
/s/ Karin Eastham
|
Member of the Board of Directors | May 27, 2008 | ||
|
||||
|
Member of the Board of Directors | May 27, 2008 | ||
|
||||
/s/ Joseph Turner
|
Member of the Board of Directors | May 27, 2008 | ||
|
Exhibit | ||
Number | Description | |
4.1
(1)
|
Form of Registrants Amended and Restated Certificate of Incorporation. | |
|
||
4.2
(2)
|
Form of Registrants Amended and Restated Bylaws. | |
|
||
4.3
(3)
|
Form of Common Stock Certificate of the Registrant. | |
|
||
5.1
|
Opinion of Cooley Godward Kronish LLP. | |
|
||
23.1
|
Consent of Independent Registered Public Accounting Firm. | |
|
||
23.2
|
Consent of Cooley Godward Kronish LLP. Reference is made to Exhibit 5.1. | |
|
||
24.1
|
Power of Attorney. Reference is made to the signature page of this Form S-8. | |
|
||
99.1
(3)
|
2005 Equity Incentive Plan and Form of Stock Option Agreement and Form of Stock Option Grant Notice thereunder. | |
|
||
99.2
(4)
|
Form of Restricted Stock Unit Grant Notice and Restricted Stock Unit Agreement for Executive Officers under the Registrants 2005 Equity Incentive Plan. | |
|
||
99.3
(3)
|
2005 Employee Stock Purchase Plan and Form of Offering Document thereunder. | |
|
||
99.4
(5)
|
2005 Non-Employee Directors Stock Option Plan and Form of Stock Option Agreement and Form of Stock Option Grant Notice thereunder. |
(1) | Filed as an exhibit to the Registrants Registration Statement on Form S-1 (File No. 33-128059) filed with the Commission on September 2, 2005, and incorporated herein by reference. | |
(2) | Filed as an exhibit to the Registrants Annual Report on Form 10-K (File No. 000-51745 ) for the year ended December 31, 2006 filed with the Commission on March 30, 2007, and incorporated herein by reference. | |
(3) | Filed as an exhibit to Amendment No. 4 to the Registrants Registration Statement on Form S-1 (File No. 33-128059) filed with the Commission on January 4, 2006, and incorporated herein by reference. | |
(4) | Filed as an exhibit to the Registrants Annual Report on Form 10-K (File No. 000-51745) for the year ended December 31, 2005 filed with the Commission on March 31, 2006, and incorporated herein by reference. | |
(5) | Filed as an exhibit to the Registrants Quarterly Report on Form 10-Q (File No. 000-51745) filed with the Commission on August 14, 2007, and incorporated herein by reference. |
1 Year Sgx Pharmaceuticals (MM) Chart |
1 Month Sgx Pharmaceuticals (MM) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions